Related Experiment Video
Updated: Jun 22, 2026
07:56
Bacterial Delivery of RNAi Effectors: Transkingdom RNAi
Published on: August 18, 2010
Carrier PNA for shRNA delivery into cells
Mizuki Kitamatsu1, Takanori Kubo, Rino Matsuzaki
1Department of Bioscience and Biotechnology, Faculty of Engineering, Okayama University, 3-1-1 Tsushimanaka, Okayama 700-0082, Japan. kitamatu@cc.okayama-u.ac.jp
Bioorganic & Medicinal Chemistry Letters
|June 2, 2009
Summary
A novel peptide nucleic acid (PNA)-cell-penetrating peptide (CPP) conjugate acts as a bridge to deliver short hairpin RNA (shRNA) into cells, successfully inducing RNA interference (RNAi). This carrier PNA system facilitates efficient gene silencing.
Area of Science:
- Biochemistry
- Molecular Biology
- Gene Therapy
Background:
- Short hairpin RNA (shRNA) is a key tool for RNA interference (RNAi) based gene silencing.
- Efficient delivery of shRNA into cells remains a challenge for therapeutic applications.
- Cell-penetrating peptides (CPPs) are known to enhance cellular uptake of biomolecules.
Purpose of the Study:
- To develop a novel carrier system for shRNA delivery using peptide nucleic acid (PNA)-CPP conjugates.
- To investigate the efficacy of the carrier PNA in forming a hybrid with shRNA and facilitating its cellular entry.
- To demonstrate RNAi induction mediated by the delivered shRNA.
Main Methods:
- Synthesis of a peptide nucleic acid (PNA)-cell-penetrating peptide (CPP) conjugate (carrier PNA).
- Formation of a hybrid between the carrier PNA and shRNA bearing complementary dangling bases.
- Introduction of the shRNA-carrier PNA complex into cells.
- Assessment of RNA interference (RNAi) induction.
Main Results:
- The carrier PNA successfully formed a hybrid with the shRNA.
- The carrier PNA facilitated the introduction of shRNA into cells.
- The delivered shRNA successfully induced RNAi, leading to gene silencing.
Conclusions:
- Peptide nucleic acid (PNA)-cell-penetrating peptide (CPP) conjugates can serve as effective 'bridge-builders' for shRNA delivery.
- This carrier PNA system enables efficient cellular uptake of shRNA and subsequent RNA interference.
- The developed system holds potential for advancing gene therapy strategies.
